ISRCTN20181108已完成不适用
The effect of Neuragen® on neuropathic pain: Double-blind, placebo-controlled clinical trial
Origin BioMed, Inc. (Canada)0 个研究点目标入组 60 人开始时间: 2008年6月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Both males and females, over 21
- •2. Diagnosed neuropathic pain for more three months
- •3. Pain level between 3-8 on a 0-10 visual pain scale
- •4. Does not have mental and communication impairments
排除标准
- •1. Pregnant
- •2. Have other types of pain
- •3. Skin condition
- •4. Central nerve impairment
研究者
相似试验
已完成
不适用
euragen® for the relief of neuropathic pain: a randomised, double-blind, placebo controlled clinical trialPeripheral neuropathyISRCTN13226601Origin BioMed, Inc. (Canada)60
已完成
不适用
euragen® for the relief of neuropathic pain part 2: a randomised, double-blind, placebo controlled clinical trialPeripheral neuropathyISRCTN08911796Origin BioMed, Inc. (Canada)60
已完成
不适用
Effect of pregabalin on neuropathic pain in Yusho patients: open label pilot studyYushoJPRN-UMIN000034468agasaki University Hospital Dermatology / Allergy Department20
已完成
不适用
Impact of pregabalin in chronic neuropathic pain after lung resectioAll diseases required lung resectionJPRN-UMIN000007757Department of General Thoracic and Cardiovascular Surgery, University of Toyama200
尚未招募
不适用
The clinical effect of pregabalin on neuropathic pain in central sensitized patients who are treated with duloxetine after total knee arthroplasty: Randomized Controlled TrialKCT0007301The Catholic University of Korea, Seoul St. Mary's Hospital90